Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Advanz Pharma, a UK headquartered global ...

Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) will be announcing its earnings results before the market opens ...

Yesterday, the European Commission fined the Israeli pharmaceutical group Teva 426.6 million euros for what it said was “abuse of a dominant position” for its drug against multiple sclerosis, Copaxone ...

Diversify Advisory Services LLC grew its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free ...

It had won regulatory approval in Europe for its rival product in 2017, describing it as “therapeutically equivalent” to ...

The European Commission has fined Israeli drugmaker Teva Pharmaceutical Industries (NYSE:TEVA) EUR 462.6M, or around $500M, for trying to ward off competition for its blockbuster multiple sclerosis ...

The European Commission has fined Israeli drugmaker Teva Pharmaceutical Industries (NYSE:TEVA) approximately $500M for disparaging a rival product to its blockbuster multiple sclerosis drug Copaxone.

The European Commission says it has fined the Israeli generic drug maker, Teva, more than €460m for improperly seeking to ...

Some two years after the European Commission accused Teva of meddling with the competition for its former multiple sclerosis blockbuster Copaxone, the other shoe has finally dropped. | The European ...

The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...

The European Commission opened formal proceedings Wednesday under the Digital Services Act against the Chinese-owned Temu e-commerce platform for allegedly selling illegal products and for having an ...